Showing results (1-10 of 615) with videos related to
Sort By:
Pageof 62
Seminars in Hematology|March 31, 2010
Rituximab in chronic lymphocytic leukemiaSamantha M Jaglowski, John C ByrdBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemiaSamantha M Jaglowski, John C ByrdBlood|July 9, 2010
The clinical application of monoclonal antibodies in chronic lymphocytic leukemiaSamantha M Jaglowski, Lapo Alinari, Rosa Lapalombella, et al.Current Opinion in Hematology|January 29, 2014
Graft-versus-host disease: why have we not made more progress?Samantha M Jaglowski, Steven M DevineBlood Advances|August 16, 2018
How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHDSamantha M Jaglowski, Bruce R BlazarJournal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Chronic lymphocytic leukemia: state of the art and beyondJohn C ByrdBritish Journal of Haematology|July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemiaSamantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.Cancer Medicine|March 17, 2017
The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemiaDaphne Guinn, Amy Lehman, Catherine Fabian, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 9, 2016
Ibrutinib for treatment of chronic lymphocytic leukemiaCory M Vela, Ali McBride, Samantha M Jaglowski, et al.Seminars in Oncology|October 20, 2009
Lymphoma in adolescents and young adultsSamantha M Jaglowski, Erica Linden, Amanda M Termuhlen, et al.Pageof 62